Catastrophic antiphospholipid syndrome (CAPS)
Multi-organ thrombosis · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Widespread small-vessel thrombosis develops over days causing multi-organ failure in a patient with antiphospholipid antibodies, often after infection or anticoagulant withdrawal. Aggressive triple therapy carries a high mortality if delayed.
Assessment
Investigations
- Identify multi-organ involvement
- Antiphospholipid antibodies
- FBC/film (may show microangiopathy)
- Imaging of affected organs
Management
- Full anticoagulation with heparin
- High-dose corticosteroids
- Plasma exchange and/or IV immunoglobulin
- Treat the trigger (e.g. infection)
- ICU and rheumatology/haematology involvement
Drugs & doses
Heparin infusion
Methylprednisolone
IVIG / plasma exchange
Disposition
ICU.
Rapid multi-organ thrombosis in a known APS patient is CAPS - escalate to triple therapy without waiting.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.